Bristol Myers Squibb Co. and Sanofi Aventis SA said Monday they filed an injunction against Apotex Corp. to stop the Canadian drug maker from selling a less expensive, generic version of the blood thinner Plavix.
Bristol Myers Sanofi Aventis try to block sales of generic Plavix.